| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2002 | CA2439730A1 Benzofuran derivatives and pharmaceutical compositions containing the same |
| 07/11/2002 | CA2435484A1 Medicinal association of a biguanide (metformin) and a carrier agent (arginine) |
| 07/11/2002 | CA2435483A1 Use as medicine of a compound restoring active principles in vivo |
| 07/11/2002 | CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | CA2434124A1 N(phenylsulphonyl)glycine derivatives and their therapeutic use |
| 07/11/2002 | CA2434072A1 Regulation of organic nitrate tolerance |
| 07/11/2002 | CA2433828A1 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | CA2433779A1 Heterocycle derivatives as ppar-gamma agonists |
| 07/11/2002 | CA2433580A1 Tertiary perfluorocycloamines as a basis for gas transport emulsions and process for preparing thereof |
| 07/11/2002 | CA2433552A1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | CA2433384A1 Neurotrophic tacrolimus analogs |
| 07/11/2002 | CA2433346A1 Method for treating glaucoma ib |
| 07/11/2002 | CA2433332A1 Agents and methods for treating pain |
| 07/11/2002 | CA2433225A1 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | CA2433125A1 Medicament containing a polyamine as an active substance |
| 07/11/2002 | CA2433041A1 Use of intermediate-conductance potassium channels and modulators for diagnosing and treating diseases involving disturbed keratinocyte activiyty |
| 07/11/2002 | CA2432959A1 Sodium channel modulators derived from 2-piperidylimidazoles |
| 07/11/2002 | CA2432504A1 Methods and compositions for treating periodontal disease |
| 07/11/2002 | CA2432184A1 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 07/11/2002 | CA2432136A1 Pharmaceutical emulsion preparation |
| 07/11/2002 | CA2431679A1 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 07/11/2002 | CA2431545A1 Excitatory amino acid receptor antagonists |
| 07/11/2002 | CA2431539A1 Skin care product containing retinoids, retinoid booster and phytoestrogens in a dual compartment package |
| 07/11/2002 | CA2431413A1 Stable skin conditioning compositions containing retinoid boosters |
| 07/11/2002 | CA2431391A1 Skin care product containing retinoids and phytoestrogens in a dual compartment package |
| 07/11/2002 | CA2431041A1 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/11/2002 | CA2430672A1 Matrix metalloproteinase inhibitors |
| 07/11/2002 | CA2430667A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | CA2428351A1 Method for detoxifying a carbohydrate containing solution |
| 07/10/2002 | EP1221615A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/10/2002 | EP1221477A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/10/2002 | EP1221446A1 Antibacterial cephalosporins |
| 07/10/2002 | EP1221445A1 Pentacyclic taxane compounds |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 07/10/2002 | EP1221326A2 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/10/2002 | EP1221316A1 Enteric-coated pharmaceutical compositions of mycophenolate |
| 07/10/2002 | EP1221315A1 Ophthalmic adhesive preparations for percutaneous absorption |
| 07/10/2002 | EP1221314A1 New crystalline form of omeprazole |
| 07/10/2002 | EP1220948A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220932A1 Human carboxypeptidases and polynucleotides encoding the same |
| 07/10/2002 | EP1220931A1 Dna encoding prost 07 polypeptide |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220921A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 07/10/2002 | EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 07/10/2002 | EP1220917A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 07/10/2002 | EP1220914A1 Human g-protein coupled receptor |
| 07/10/2002 | EP1220913A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 07/10/2002 | EP1220911A2 P-glycoproteins and uses thereof |
| 07/10/2002 | EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 07/10/2002 | EP1220903A1 Gene selection using pnas |
| 07/10/2002 | EP1220866A1 Antisense modulation of bcl-6 expression |
| 07/10/2002 | EP1220863A1 Purine derivatives |
| 07/10/2002 | EP1220862A1 Purine derivatives |
| 07/10/2002 | EP1220858A2 Oxazinoquinolones useful for the treatment of viral infections |
| 07/10/2002 | EP1220857A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/10/2002 | EP1220856A2 Pyrazolo[4,3-d]pyrimidine derivatives |
| 07/10/2002 | EP1220855A2 Anhydrous salt |
| 07/10/2002 | EP1220854A2 Novel tropane analogs |
| 07/10/2002 | EP1220853A1 Piperidine derivatives as serotonine reuptake inhibitors |
| 07/10/2002 | EP1220852A1 Substituted diazepans |
| 07/10/2002 | EP1220849A2 Bicyclic compounds composition and method for stabilizing the same |
| 07/10/2002 | EP1220848A2 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv |
| 07/10/2002 | EP1220845A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
| 07/10/2002 | EP1220844A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 07/10/2002 | EP1220843A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 07/10/2002 | EP1220842A1 Cyclic amine compounds as ccr5 antagonists |
| 07/10/2002 | EP1220840A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP1220839A2 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors |
| 07/10/2002 | EP1220838A2 1-aziridino-1-hydroxyiminomethyl-derivatives, method for the production thereof and medicaments containing said compounds |
| 07/10/2002 | EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP1220832A1 Novel aromatic compounds |
| 07/10/2002 | EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 07/10/2002 | EP1220830A1 Systems and methods for opening obstructed biological conduits |
| 07/10/2002 | EP1220699A1 Medicament pack |
| 07/10/2002 | EP1220690A2 Injection vehicle for polymer-based formulations |
| 07/10/2002 | EP1220689A2 Treatment of fatigue, head injury and stroke |
| 07/10/2002 | EP1220684A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/10/2002 | EP1220680A2 Echinacea supplement and method of manufacture |
| 07/10/2002 | EP1220678A2 Pharmaceutical compositions containing copper, salicylic acid and vitamin c |
| 07/10/2002 | EP1220676A1 Prevention of colorectal cancer |
| 07/10/2002 | EP1220674A1 Pharmaceutical product suitable for use immunosuppressive therapy |
| 07/10/2002 | EP1220673A2 Morpholinol derivatives for the treatment of obesity |
| 07/10/2002 | EP1220672A1 Medicament for treatment of neuropathies |
| 07/10/2002 | EP1220671A2 Use of n-acyl homoserine lactones for the treatment of cardiac tachyarrhythmias, ischaemic heart disease or congestive heart failure |
| 07/10/2002 | EP1220670A1 Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use |
| 07/10/2002 | EP1220669A1 Therapeutic intervention to mimic the effect of caloric restriction |
| 07/10/2002 | EP1220668A1 Use of diminazene-di-aceturate for treating malaria |
| 07/10/2002 | EP1220667A2 Treating endometriosis or infertility, or improving fertility |
| 07/10/2002 | EP1220666A2 Methods for modulating the human sexual response |
| 07/10/2002 | EP1220665A1 Hop acids used to inhibit staphylococcus aureus |
| 07/10/2002 | EP1220663A1 Superficial therapeutic system for topically applying acetylsalicylic acid, for the treatment of acne-related diseases |
| 07/10/2002 | EP1220662A1 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 07/10/2002 | EP1220661A2 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid |
| 07/10/2002 | EP1220658A1 Melt granulated composition and modified release dosage form prepared from said composition |
| 07/10/2002 | EP1220657A1 Liposome encapsulated silver salt compositions |
| 07/10/2002 | EP1220656A2 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase |
| 07/10/2002 | EP1220620A1 Composition comprising casein protein and whey protein |
| 07/10/2002 | EP1220617A1 Fish feed with increased nucleotide content |